Article
The Microbiome and p-Inulin in Hemodialysis: A Feasibility Study
15 Jan 2021
Abstract excerpt
Background The intestinal microbiome is an appealing target for interventions in ESKD because of its likely contribution to uremic toxicity. Before conducting clinical trials of microbiome-altering treatments, it is necessary to understand the within-person and between-person variability in the composition and function of the gut microbiome in patients with ESKD. Methods We conducted a multicenter, nonrandomized,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
